BU-NOT-SET

CONTACT US
Enhancing the production of RNA with continuous manufacturing
  • Biologics
Continuous manufacturing of RNA
Insight
GERTEIS MINI-PACTOR® Advanced dry granulation services
  • Drug product
GERTEIS MINI-PACTOR®
Fact sheet
Overcoming oncolytic virus therapy production challenges through collaboration
  • Biologics
Oncolytic virus therapy production
Case study
Emerging trends set to impact drug development in 2024
  • Industry trends
Trends in drug development
Insight
Webinar: ATMPs in focus: Essential CMC strategies for every phase
  • Biologics
ATMPs in focus
Webinar
Trends set to make an impact on oral solid dose development in 2024
  • Drug product
  • Industry trends
Oral solid dose
Insight
Enhancing AAV therapy development and manufacture with a platform approach
  • Biologics
Enhancing AAV therapy
Insight
Challenges and solutions to enhancing mRNA stability with lyophilisation processes
  • Drug product
  • Industry trends
Lyo
Insight
A well-equipped CDMO for OSD contract manufacturing
  • Industry trends
  • Manufacturing
OSD contract manufacturing
Insight
Fact sheet
  • Biologics
Plasmid DNA manufacturing capabilities
Insight
  • Analytical chemistry
  • Drug substance
Leveraging analytics throughout development and manufacture to achieve commercial success
Insight
  • Sustainability
2,300 solar panels installed at Recipharm’s Holmes Chapel
White paper
  • Analytical chemistry
  • Drug substance
Analysing prebiotic oligosaccharides for future product innovation
Insight
  • Industry trends
  • Manufacturing
Enhancing sterile processing for future vaccine programs
Insight
  • Sustainability
Increasing carbon emission transparency through SBTi contributions
Insight
  • Biologics
Single-use technologies are enabling increasing demand for biologics
Insight
  • Biologics
Overcoming the challenges surrounding manufacturing oncolytic viruses
Insight
  • Drug product
  • Industry trends
Insights from DCAT Week: Exploring drug storage, drug dosage and the supply chain